EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures

Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier

Infectious Diseases and Therapy · 2024-08 · 13 (8) · 1725-1742

DOI: 10.1007/s40121-024-01012-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infectious Diseases and Therapy, online erschienen am 06.07.2024. Verfasst von Charles Nuttens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Vaccines, Paris, France. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Clinical severityEpidemiologyMonoclonal antibodiesRSV subgroupsRespiratory syncytial virusVaccines

Autor:innen und Institutionen

  • Pfizer Vaccines, Paris, France.
  • Epidemiology & Pharmacovigilance, P95, Louvain, Belgium.
  • Pfizer Vaccines, Madrid, Spain.
  • Pfizer Vaccines, Collegeville, PA, USA.
  • Scientific Affairs, Older Adult RSV Vaccine Program, Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, 9 Riverwalk, Citywest Business Campus, Dublin 24, Dublin, Ireland. Elizabeth.Begier@pfize…

Förderung

  • Pfizer Inc

Zitieren

APA

Nuttens, C., Moyersoen, J., Curcio, D., Aponte-Torres, Z., Baay, M., Vroling, H., Gessner, B. D., & Begier, E. (2024). Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious Diseases and Therapy, 13(8), 1725-1742. https://doi.org/10.1007/s40121-024-01012-2

Vancouver

Nuttens C, Moyersoen J, Curcio D, Aponte-Torres Z, Baay M, Vroling H, et al. Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious Diseases and Therapy. 2024;13(8):1725-1742. doi:10.1007/s40121-024-01012-2

BibTeX
@article{Nuttens2024,
  author = {Nuttens, Charles and Moyersoen, Juliette and Curcio, Daniel and Aponte-Torres, Zuleika and Baay, Marc and Vroling, Hilde and Gessner, Bradford D and Begier, Elizabeth},
  title = {Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures},
  journal = {Infectious Diseases and Therapy},
  year = {2024},
  volume = {13},
  number = {8},
  pages = {1725--1742},
  doi = {10.1007/s40121-024-01012-2}
}
Kostenlos starten →